114 related articles for article (PubMed ID: 38636083)
21. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
Okugawa Y; Toiyama Y; Oki S; Ide S; Yamamoto A; Ichikawa T; Kitajima T; Fujikawa H; Yasuda H; Saigusa S; Hiro J; Yoshiyama S; Kobayashi M; Araki T; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):998-1007. PubMed ID: 29786882
[TBL] [Abstract][Full Text] [Related]
22. Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS
Radiat Oncol J; 2017 Sep; 35(3):217-226. PubMed ID: 29037019
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Preoperative Radiotherapy Versus Chemoradiotherapy in Advanced Rectal Cancer: A Meta-analysis of Randomized Controlled Trials.
Yu M; Wang DC; Li S; Huang LY; Wei J
Am Surg; 2023 Jun; 89(6):2262-2271. PubMed ID: 35435026
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.
Senyurek S; Saglam S; Saglam EK; Yanar H; Gok K; Tastekin D; Akbas CK; Sakin ND; Kartal GD; Balik E; Keskin M; Sanli Y; Gulluoglu M; Akgun Z
Oncol Res; 2023; 31(5):689-696. PubMed ID: 37547762
[TBL] [Abstract][Full Text] [Related]
25. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial.
Lee JL; Lim SB; Yu CS; Park IJ; Yoon YS; Kim CW; Park SH; Lee JS; Hong YS; Kim SY; Kim JE; Kim JH; Park JH; Kim J; Han M
BMC Cancer; 2019 Apr; 19(1):404. PubMed ID: 31035949
[TBL] [Abstract][Full Text] [Related]
26. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
[TBL] [Abstract][Full Text] [Related]
27. Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment tolerability and anastomotic leakage.
Yamano T; Yoshimura M; Kobayashi M; Beppu N; Hamanaka M; Babaya A; Tsukamoto K; Noda M; Matsubara N; Tomita N
Int J Colorectal Dis; 2016 Apr; 31(4):877-84. PubMed ID: 26888783
[TBL] [Abstract][Full Text] [Related]
28. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
29. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
[TBL] [Abstract][Full Text] [Related]
31. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
[TBL] [Abstract][Full Text] [Related]
32. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
33. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials.
Song JH; Jeong JU; Lee JH; Kim SH; Cho HM; Um JW; Jang HS;
Radiat Oncol J; 2017 Sep; 35(3):198-207. PubMed ID: 29037017
[TBL] [Abstract][Full Text] [Related]
34. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
35. Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation.
Deidda S; Elmore U; Rosati R; De Nardi P; Vignali A; Puccetti F; Spolverato G; Capelli G; Zuin M; Muratore A; Danna R; Calabrò M; Guerrieri M; Ortenzi M; Ghiselli R; Scabini S; Aprile A; Pertile D; Sammarco G; Gallo G; Sena G; Coco C; Rizzo G; Pafundi DP; Belluco C; Innocente R; Degiuli M; Reddavid R; Puca L; Delrio P; Rega D; Conti P; Pastorino A; Zorcolo L; Pucciarelli S; Aschele C; Restivo A
JAMA Surg; 2021 Dec; 156(12):1141-1149. PubMed ID: 34586340
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer.
Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY
Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665
[TBL] [Abstract][Full Text] [Related]
37. Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer.
Yoon WH; Kim HJ; Kim CH; Joo JK; Kim YJ; Kim HR
Ann Surg Treat Res; 2015 Jan; 88(1):15-20. PubMed ID: 25553320
[TBL] [Abstract][Full Text] [Related]
38. Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched Analysis.
Yamaguchi T; Akiyoshi T; Fukunaga Y; Sakamoto T; Mukai T; Hiyoshi Y; Nagasaki T; Taguchi S; Chino A; Shinozaki E; Yamaguchi K; Konishi T
Ann Surg Oncol; 2023 Aug; 30(8):4716-4724. PubMed ID: 37032405
[TBL] [Abstract][Full Text] [Related]
39. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
40. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
